Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Trims Stock Holdings in Church & Dwight Co., Inc. (NYSE:CHD)

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA lowered its position in shares of Church & Dwight Co., Inc. (NYSE:CHD) by 1.2% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 1,311,816 shares of the company’s stock after selling 16,365 shares during the period. Church & Dwight comprises about 1.2% of Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s investment portfolio, making the stock its 26th largest position. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s holdings in Church & Dwight were worth $134,619,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently modified their holdings of CHD. Wealth Enhancement Advisory Services LLC boosted its stake in Church & Dwight by 19.2% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 20,994 shares of the company’s stock worth $2,190,000 after acquiring an additional 3,388 shares in the last quarter. Miracle Mile Advisors LLC bought a new stake in shares of Church & Dwight in the 1st quarter worth approximately $338,000. Norden Group LLC grew its stake in shares of Church & Dwight by 2,746.5% in the 1st quarter. Norden Group LLC now owns 84,768 shares of the company’s stock worth $8,842,000 after buying an additional 81,790 shares during the last quarter. Wealthstar Advisors LLC bought a new position in Church & Dwight during the 1st quarter valued at approximately $1,350,000. Finally, First Trust Direct Indexing L.P. raised its stake in Church & Dwight by 5.5% during the first quarter. First Trust Direct Indexing L.P. now owns 12,671 shares of the company’s stock valued at $1,322,000 after buying an additional 666 shares during the last quarter. Institutional investors own 86.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently commented on CHD. Barclays increased their target price on Church & Dwight from $82.00 to $86.00 and gave the stock an “underweight” rating in a research note on Friday, October 11th. Evercore ISI reduced their price objective on shares of Church & Dwight from $110.00 to $101.00 and set an “in-line” rating for the company in a research note on Monday, August 5th. Stifel Nicolaus decreased their target price on shares of Church & Dwight from $107.00 to $105.00 and set a “hold” rating for the company in a report on Monday, August 5th. Truist Financial cut their price target on shares of Church & Dwight from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Monday, August 5th. Finally, Piper Sandler initiated coverage on Church & Dwight in a research report on Tuesday, September 24th. They issued an “overweight” rating and a $120.00 price objective on the stock. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $107.50.

Insider Activity

In related news, EVP Barry A. Bruno sold 59,328 shares of the firm’s stock in a transaction on Monday, August 5th. The stock was sold at an average price of $99.37, for a total value of $5,895,423.36. Following the transaction, the executive vice president now directly owns 4,319 shares of the company’s stock, valued at approximately $429,179.03. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.40% of the company’s stock.

Church & Dwight Stock Performance

NYSE:CHD traded up $0.13 on Wednesday, hitting $100.76. The stock had a trading volume of 61,644 shares, compared to its average volume of 1,352,599. Church & Dwight Co., Inc. has a 52-week low of $82.25 and a 52-week high of $110.31. The stock has a market cap of $24.67 billion, a price-to-earnings ratio of 30.96, a price-to-earnings-growth ratio of 3.72 and a beta of 0.54. The company has a quick ratio of 0.98, a current ratio of 1.53 and a debt-to-equity ratio of 0.51. The business’s 50-day simple moving average is $102.93 and its two-hundred day simple moving average is $104.05.

Church & Dwight (NYSE:CHD) last posted its quarterly earnings data on Friday, August 2nd. The company reported $0.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.84 by $0.09. Church & Dwight had a net margin of 13.38% and a return on equity of 19.86%. The company had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.51 billion. During the same quarter last year, the firm posted $0.92 earnings per share. The firm’s revenue was up 3.9% compared to the same quarter last year. As a group, research analysts predict that Church & Dwight Co., Inc. will post 3.43 earnings per share for the current year.

About Church & Dwight

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.